Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| XERIS BIOPHARMA HOLDINGS INC | 5,113,348 | 5,113,348 | 0 | 11,505 | 14,573 | 60.31% | +3,068 |
| REZOLUTE INC | 1,318,967 | 1,318,967 | 0 | 5,672 | 6,397 | 26.47% | +725 |
| SPDR S&P 500 ETF TR(SPY) | 1,869 | 2,867 | +998 | 1,017 | 1,645 | 6.81% | +628 |
| BICARA THERAPEUTICS INC | 0 | 10,941 | +10,941 | 0 | 279 | 1.15% | +279 |
| BERKSHIRE HATHAWAY INC DEL | 1,025 | 1,151 | +126 | 417 | 530 | 2.19% | +113 |
| COMPASS THERAPEUTICS INC | 43,465 | 43,465 | 0 | 43 | 80 | 0.33% | +37 |
| ADICET BIO INC | 17,488 | 17,488 | 0 | 21 | 25 | 0.10% | +4 |
| CONTEXT THERAPEUTICS INC | 18,403 | 18,403 | 0 | 37 | 36 | 0.15% | -1 |
| MIND MEDICINE MINDMED INC | 30,383 | 34,073 | +3,690 | 219 | 194 | 0.80% | -25 |
| ABIVAX SA(ABVX) | 13,900 | 11,365 | -2,535 | 184 | 131 | 0.54% | -53 |
| KYVERNA THERAPEUTICS INC | 22,981 | 22,981 | 0 | 172 | 112 | 0.47% | -60 |
| LEXEO THERAPEUTICS INC | 17,851 | 17,851 | 0 | 286 | 161 | 0.67% | -125 |
| MOLECULAR TEMPLATES INC | 136,866 | 0 | -136,866 | 157 | 0 | — | -157 |